{"nct_id":"NCT00161993","title":"Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2002-06-13","start_date_type":"ACTUAL","primary_completion_date":"2003-09-24","primary_completion_date_type":"ACTUAL","completion_date":"2003-09-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}